Evidence checked as of October 2026. Written by The Wellness Team.
Can spironolactone treat female pattern hair loss?
Spironolactone is a blood-pressure medicine that also blocks androgen receptors, and dermatologists have used it off-label for female pattern hair loss for years. The logic is sound: female pattern loss is driven by the effect of androgens on genetically sensitive follicles, so reducing that effect can slow loss and, in some women, thicken what remains. It is not licensed for hair loss in the UK, which means it is prescribed on a specialist, off-label basis with proper consent.
The honest summary is that it works for a meaningful proportion of women, not all of them, and it takes six to twelve months to judge. It is a brake and sometimes a partial reverse, not a regrowth guarantee.
How strong is the evidence?
The evidence base is real but modest: case series and open-label studies rather than large randomised trials. A 2018 pilot study by Sinclair reported improved hair density in women treated with a combination of low-dose oral minoxidil and spironolactone over twelve months, and earlier reviews by the same group describe stable or improved density in most women on spironolactone alone. A 2024 retrospective review of the same minoxidil and spironolactone combination reported durable efficacy with an acceptable safety profile over long follow-up.
What this means for you: the treatment is rational, supervised and worth considering, but no treatment can honestly guarantee a response. Diagnosis first, always, because spironolactone does nothing for hair loss that is not androgen-driven.
Who should not take it?
Spironolactone is unsuitable in pregnancy because of its anti-androgen effects on a developing baby, so reliable contraception is essential for women who could become pregnant. It raises potassium and lowers blood pressure, so it needs care in kidney disease, with certain blood-pressure medicines, and in anyone already prone to low blood pressure or fainting. Baseline blood tests and periodic monitoring are part of the package, not an optional extra.
What should be checked before any treatment?
Hair loss in women has more than one common cause, and the treatments differ completely. Before anything is prescribed, the basics are ferritin and iron stores, thyroid function, and, where the history suggests it, hormone profiles. Diffuse shedding after illness, weight loss or childbirth is usually telogen effluvium, which recovers on its own; pattern loss at the parting and crown is the androgen-driven type spironolactone addresses. A trichoscopy examination separates them in one visit.
How does it fit with PRP?
They work on different mechanisms, so they combine sensibly. Spironolactone reduces the hormonal drive that miniaturises the follicle; PRP delivers growth factors that support the follicle itself. For many women the best results come from a plan that pairs medical treatment, where appropriate, with a PRP course, then tracks progress with standardised photographs rather than memory.
As of October 2026, a hair-loss consultation at The London PRP Clinic is £150 and includes the assessment and blood-test review; a PRP course of three sessions is £1,215. Any prescription decision sits with the doctor after examination and bloods.
Book a hair-loss consultation or message us on WhatsApp.
Evidence and limits
Sinclair RD 2018: pilot study of low-dose oral minoxidil combined with spironolactone for female pattern hair loss: https://pubmed.ncbi.nlm.nih.gov/29231239/
Retrospective review 2024: long-term efficacy and safety of the low-dose minoxidil and spironolactone combination: https://pubmed.ncbi.nlm.nih.gov/39399339/
This is general information, not a prescription or a personal recommendation. Spironolactone for hair loss is off-label, needs medical supervision, and is unsuitable in pregnancy.